Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA 1 is a highly conserved, approximately 120-nucleotide non-coding RNA molecule that is an integral component of the large subunit of cytoplasmic ribosomes in eukaryotes and prokaryotes, with the exception of animal and fungal mitochondrial ribosomes. It plays a critical architectural role within the central protuberance of the ribosome, physically bridging and coordinating communication among multiple functional centers necessary for protein synthesis. It interacts with ribosomal proteins and domains of large subunit rRNA to facilitate biogenesis, subunit assembly, and proper translation fidelity. While essential for ribosome structure and function, it is not itself a therapeutic drug target, nor is it a receptor, enzyme, or transporter.
Not applicable, as there are no drugs targeting 5S rRNA 1. Antibiotics affecting the ribosome may indirectly disturb 5S rRNA’s structural context, but they do not bind or modulate 5S rRNA directly.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA 1 (5S rRNA 1).